viernes, 30 de enero de 2015

Revistas Enero 2015 con acceso libre/Free access Jan 2015 journals

Atentamente
Anestesia y Medicina del Dolor

Bupivacaina intraperitoneal/Intraperitoneal bupivacaine


Nuevo portal / New website

Ya pueden visitar nuestro nuevo portal anestesia-dolor.org. Seguiremos trabajando por una mejor educación virtual.
You can now visit our new website anestesia-dolor.org . We will continue working for a better virtual education.
Comparación de bupivacaína, sulfato de magnesio y su combinación para analgesia postoperatoria en pacientes de colecistectomía laparoscópica
Comparative evaluation of intraperitoneal bupivacaine, magnesium sulfate and their combination for postoperative analgesia in patients undergoing laparoscopic cholecystectomy.
Anand S, Bajwa SS, Kapoor B B, Jitendera M, Gupta H.
Niger J Surg Sci [serial online] 2014 [cited 2015 Jan 21];24:42-8.
Abstract
Background: Various multimodal techniques have been employed time and again to allay visceral pain after laparoscopic cholecystectomy. Aim: The aim of this study was to assess and compare the postoperative pain relief in patients undergoing laparoscopic cholecystectomy with intraperitoneal administration of bupivacaine, magnesium sulfate and their combination. Materials and Methods:Patients were randomly divided into four groups of 20 each. Patients in group I "C" received 50 ml of 0.9% saline, group II "B" received 50 ml of 0.25% bupivacaine, group III "M" received 50 ml of 30 mg/kg magnesium sulfate, while patients in group IV "MB" received 0.125% of bupivacaine with 15 mg/kg of magnesium sulfate to a total volume of 50 ml after surgery. Postoperatively pain was assessed using visual analog scale (VAS) and postoperative pain (VAS > 3) was managed with intravenous tramadol 50 mg. Time to the first request of analgesia, the total number of analgesic doses of tramadol, the incidence and severity of postoperative shoulder pain in 24 h and presence of complications if any were noted. Results: Demographic profile of patients of all the four groups was comparable and statistically nonsignificant. Intraperitoneal instillation of 0.25% bupivacaine provided longest duration of analgesia for 541.5 ΁ 131.48 min with a significant reduction in the number of doses of intramuscular tramadol in 24 h. Intraperitoneal instillation of 30 mg/kg magnesium sulfate provided analgesia for 82.25 ΁ 35.37 min with no significant reduction in a number of doses of intramuscular tramadol in 24 h when compared to control. Intraperitoneal instillation of mixture of bupivacaine and magnesium sulfate in reduced doses, that is, 0.125% bupivacaine and 15 mg/kg magnesium sulfate provided analgesia for 305 ΁ 65.64 min with a significant reduction in a number of doses of intramuscular tramadol in 24 h. There was reduced incidence and severity of shoulder pain, which was comparable in all the four groups. No significant side-effects were seen in any of the groups. Conclusion: Intrape-ritonel administration of bupivacaine, magnesium sulfate and their combination in reduced doses provides effective postoperative analgesia in laparoscopic cholecystectomy patients though their combination when the doses of both the drugs were reduced to half was less effective than bupivacaine group alone. Furthermore, bupivacaine and magnesium sulfate serve as useful adjuncts to postoperative analgesics.
Keywords: Bupivacaine, laparoscopic cholecystectomy, magnesium sulphate, postoperative analgesia
PDF 
Comparando el impacto de hidrocortisona con bupivacaína intraperitoneales sobre el dolor después de colecistectomía laparoscópica
Comparing the impact of intraperitoneal hydrocortisone with bupivacaine on postoperative pain after laparoscopic cholecystectomy.
Amini S, Sabzi Sarvestani A
Anesth Pain Med. 2014 Sep 8;4(4):e17206. doi: 10.5812/aapm.17206. eCollection 2014.
Abstract
BACKGROUND: Postoperative pain is a major complaint following laparoscopic cholecystectomy. OBJECTIVES: The aim of this study was to compare the impact of intraperitoneal hydrocortisone with intraperitoneal bupivacaine on pain relief after laparoscopic cholecystectomy. PATIENTS AND METHODS: In a double blind clinical trial, 63 candidates for laparoscopic cholecystectomy were randomly allocated to receiveintraperitoneal instillation of either 100 mg bupivacaine in 250 mL normal saline (n = 32) or 100 mg hydrocortisone in 250 mL normal saline (n = 31) before insufflation of CO2 into the peritoneum for postoperative pain relief. Patients were investigated regarding abdominal and shoulder pain using (visual analog scale) VAS in recovery room and at 6, 12 and 24 hours postoperatively. Patients were also followed regarding postoperative analgesic requirements, nausea and vomiting, and return of bowel function. RESULTS: Sixty patients completed the study. Patients in the hydrocortisone group had no statistically significant abdominal and shoulder pain scores compared to the bupivacaine group. The patients were similar regarding postoperative analgesic requirements, return of bowel function, nausea and vomiting. No adverse effect was detected in either group. CONCLUSIONS: Intraperitoneal administration of hydrocortisone is as effective as bupivacaine to reduce pain and analgesic requirements after laparoscopic cholecystectomy.
KEYWORDS: Bupivacaine; Cholecystectomy; Hydrocortisone; Intraperitoneal Injection; Postoperative Pain
Efecto de bupivacaína intraperitoneal sobre la nausea y vomito postoperatorios después de colecistectomía laparoscópica
Intraperitoneal bupivacaine effect on postoperative nausea and vomiting following laparoscopic cholecystectomy.
Yari M, Rooshani B, Golfam P, Nazari N.
Anesth Pain Med. 2014 Jul 8;4(3):e16710. doi: 10.5812/aapm.16710. eCollection 2014.
Abstract
BACKGROUND: Postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy (LC) has multifactorial etiology. Pain and use of opioids are among the important factors. OBJECTIVES: The present study aimed to evaluate the efficacy of intrapritoneal (IP) injection of bupivacaine on PONV. PATIENTS AND METHODS: This was a double-blind randomized clinical trial, conducted on 66 patients aged 20-60, ASA I or II, candidates for LC. Patients were randomly assigned to two groups. Bupivacaine group received 20 mL bupivacaine 0.25% in the gallbladder bed, before and after cholecystectomy and the control group did not. The incidence of nausea and postoperative pain intensity was measured with Visual analogue scale (VAS) at 1, 2, 3 and 4 hours after operation, at rest and when coughing and changing positions. Nausea and vomiting occurrence were assessed at the same times. RESULTS: There were no demographic data differences between groups. No differences were found between the two groups, in terms of incidence of nausea and vomiting. Furthermore, both groups were similar with respect to opioid consumption, during four hours post-operation. CONCLUSIONS:Intraperitoneal bupivacaine administration at the beginning and end of laparoscopic cholecystectomy reduced only visceral and shoulder pains at the 4th postoperative hour, but had no effect on reducing neither PONV, nor opioid demand, during the first four postoperative hours.
KEYWORDS: Bupivacaine; Cholecystectomy; Laparoscopic; Postoperative Nausea and Vomiting
PDF
Atentamente
Anestesia y Medicina del Dolor

Condroprotección. Novedades de las revistas más importantes en Condroprotección




condroproteccion.es


30 de enero de 2015


A continuación le mostramos las novedades de las revistas más importantes en Condroprotección. 
 
 
El Blog de la Condroprotección 

 Diagnóstico asistido por ordenador de la artrosis inicial de rodilla basado en el mapeo por IRM T2 
 Biomed Mater Eng. 2014 Jan 1;24(6):3379-88. doi: 10.3233/BME-141161. 
 Aparición de síntomas, diagnóstico y manejo de la artrosis 
 Health Rep. 2014 Sep 17;25(9):10-7. 




Annals of the Rheumatic Diseases


Annals of the Rheumatic Diseases
January 2015, Volume 74, Issue 1
Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the Global Burden of Disease 2010 Study and the next steps forward
Damian G Hoy, Emma Smith, Marita Cross, Lidia Sanchez-Riera, Fiona M Blyth, Rachelle Buchbinder, Anthony D Woolf, Tim Driscoll, Peter Brooks, Lyn M March
 
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
Désirée van der Heijde, Daniel Aletaha, Loreto Carmona, Christopher J Edwards, Tore K Kvien, Marios Kouloumas, Pedro Machado, Sue Oliver, Maarten de Wit, Maxime Dougados
 
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
Mollie N Carruthers, Arezou Khosroshahi, Tamara Augustin, Vikram Deshpande, John H Stone
 
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
Paul Emery, Gerd R Burmester, Vivian P Bykerk, Bernard G Combe, Daniel E Furst,Emilie Barré, Chetan S Karyekar, Dennis A Wong, Tom W J Huizinga
 
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
P Verschueren, D De Cock, L Corluy, R Joos, C Langenaken, V Taelman, F Raeman, I Ravelingien, K Vandevyvere, J Lenaerts, E Geens, P Geusens, J Vanhoof, A Durnez, J Remans, B Vander Cruyssen, E Van Essche, A Sileghem, G De Brabanter, J Joly, S Meyfroidt, K Van der Elst, R Westhovens
 
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
T W J Huizinga, Philip G Conaghan, Emilio Martin-Mola, Georg Schett, Howard Amital,Ricardo M Xavier, Orrin Troum, Maher Aassi, Corrado Bernasconi, Maxime Dougados
 
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study
A Kavanaugh, D Gladman, D van der Heijde, O Purcaru, P Mease
 
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
Sofia Ramiro, Carmen Stolwijk, Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados, Filip van den Bosch, Robert Landewé
 
Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag Health Study (HUNT)
Mari Hoff, Agnete Malm Gulati, Pål Richard Romundstad, Arthur Kavanaugh, Glenn Haugeberg
 
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis
Carmen Stolwijk, Astrid van Tubergen, José Dionisio Castillo-Ortiz, Annelies Boonen
 
Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham Heart Study
Ida K Haugen, Vasan S Ramachandran, Devyani Misra, Tuhina Neogi, Jingbo Niu,Tianzhong Yang, Yuqing Zhang, David T Felson
 
Cross-sectional and longitudinal associations between circulating leptin and knee cartilage thickness in older adults
Oliver P Stannus, Yuelong Cao, Benny Antony, Leigh Blizzard, Flavia Cicuttini, Graeme Jones, Changhai Ding
 
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use
Susanna M Proudman, Michael J James, Llewellyn D Spargo, Robert G Metcalf, Thomas R Sullivan, Maureen Rischmueller, Katerina Flabouris, Mihir D Wechalekar, Anita T Lee,Leslie G Cleland
 
Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
V P Bykerk, J Cush, K Winthrop, L Calabrese, O Lortholary, M de Longueville, R van Vollenhoven, X Mariette
 
Responsiveness and minimally important difference for the Patient-Reported Outcomes Measurement Information System (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis
Ron D Hays, Karen L Spritzer, James F Fries, Eswar Krishnan
 
Self-management approaches for osteoarthritis in the hand: a 2×2 factorial randomised trial
Krysia Dziedzic, Elaine Nicholls, Susan Hill, Alison Hammond, June Handy, Elaine Thomas, Elaine Hay
 
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Alper M van Sijl, Izhar C van Eijk, Mike J L Peters, Erik H Serné, Irene E van der Horst-Bruinsma, Yvo M Smulders, Michael T Nurmohamed
 
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre
Gemma Lepri, Serena Guiducci, Silvia Bellando-Randone, Iacopo Giani, Cosimo Bruni,Jelena Blagojevic, Giulia Carnesecchi, Alessandra Radicati, Filippo Pucciani, Matucci-Cerinic Marco
 
The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK
Joanna C Robson, Amit Kiran, Joe Maskell, Andrew Hutchings, Nigel Arden, Bhaskar Dasgupta, William Hamilton, Akan Emin, David Culliford, Raashid A Luqmani
 
Erosive osteoarthritis: a more severe form of radiographic hand osteoarthritis rather than a distinct entity?
Michelle Marshall, Elaine Nicholls, Wing-Yee Kwok, George Peat, Margreet Kloppenburg,Danielle van der Windt, Helen Myers, Krysia Dziedzic
 
Revisiting comorbidities in gout: a cluster analysis
Pascal Richette, Pierre Clerson, Laure Périssin, René-Marc Flipo, Thomas Bardin
 
Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register
C Austad, T K Kvien, I C Olsen, T Uhlig
 
The population prevalence of symptomatic radiographic foot osteoarthritis in community-dwelling older adults: cross-sectional findings from the Clinical Assessment Study of the Foot
Edward Roddy, Martin J Thomas, Michelle Marshall, Trishna Rathod, Helen Myers, Hylton B Menz, Elaine Thomas, George Peat
 
Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: a long-term follow-up of a randomised trial
Ida Svege, Lars Nordsletten, Linda Fernandes, May Arna Risberg
 
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk
Annie Yarwood, Buhm Han, Soumya Raychaudhuri, John Bowes, Mark Lunt, Dimitrios A Pappas, Joel Kremer, Jeffrey D Greenberg, Robert Plenge, Rheumatoid Arthritis Consortium International (RACI), Jane Worthington, Anne Barton, Steve Eyre
 
Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
Joanna Robson, Helen Doll, Ravi Suppiah, Oliver Flossmann, Lorraine Harper, Peter Höglund, David Jayne, Alfred Mahr, Kerstin Westman, Raashid Luqmani
 
High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis
Ai Lyn Tan, Eiji Fukuba, Nicola Ann Halliday, Steven F Tanner, Paul Emery, Dennis McGonagle
 
Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
Zachary S Wallace, Hamid Mattoo, Mollie Carruthers, Vinay S Mahajan, Emanuel Della Torre, Hang Lee, Maria Kulikova, Vikram Deshpande, Shiv Pillai, John H Stone
 
Role of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis
D A Binks, E M Gravallese, D Bergin, R J Hodgson, A L Tan, M M Matzelle, D McGonagle,A Radjenovic
 
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease
Hemlata Varsani, Susan C Charman, Charles K Li, Suely K N Marie, Anthony A Amato,Brenda Banwell, Kevin E Bove, Andrea M Corse, Alison M Emslie-Smith, Thomas S Jacques, Ingrid E Lundberg, Carlo Minetti, Inger Nennesmo, Elisabeth J Rushing,Adriana M E Sallum, Caroline Sewry, Clarissa A Pilkington, Janice L Holton, Lucy R Wedderburn, the UK Juvenile Dermatomyositis Research Group
 
Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis
M I P Ramos, O N Karpus, P Broekstra, S Aarrass, S E Jacobsen, P P Tak, M C Lebre
 
Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice
Emmanuel Coste, Iain R Greig, Patrick Mollat, Lorraine Rose, Mohini Gray, Stuart H Ralston, Rob J van t Hof
 
Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells
Stephan Blüml, Martin Friedrich, Tobias Lohmeyer, Emine Sahin, Victoria Saferding, Julia Brunner, Antonia Puchner, Peter Mandl, Birgit Niederreiter, Josef S Smolen, Gernot Schabbauer, Kurt Redlich
 
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
Yoann Rombouts, Ewoud Ewing, Lotte A van de Stadt, Maurice H J Selman, Leendert A Trouw, André M Deelder, Tom W J Huizinga, Manfred Wuhrer, Dirkjan van Schaardenburg, René E M Toes, Hans U Scherer
 
AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis
Cleo S Bonnet, Anwen S Williams, Sophie J Gilbert, Ann K Harvey, Bronwen A Evans,Deborah J Mason
 
Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain
S Kelly, R J Chapman, S Woodhams, D R Sagar, J Turner, J J Burston, C Bullock, K Paton, J Huang, A Wong, D F McWilliams, B N Okine, D A Barrett, G J Hathway, D A Walsh, V Chapman
 
FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells
Chiara Bocelli-Tyndall, Emanuele Trella, Audrey Frachet, Paul Zajac, Dennis Pfaff, Jeroen Geurts, Stefan Heiler, Andrea Barbero, Marcus Mumme, Therese J Resink, Stefan Schaeren, Giulio C Spagnoli, Alan Tyndall
 
Inhibition of Notch signalling ameliorates experimental inflammatory arthritis
Jong-Sung Park, Seol-Hee Kim, Kwangmeyung Kim, Cheng-Hao Jin, Ki Young Choi,Jiyeon Jang, Yuri Choi, A-Ryeong Gwon, Sang-Ha Baik, Ui Jeong Yun, Su Young Chae,Seulki Lee, Young Mo Kang, Kang Choon Lee, Thiruma V Arumugam, Mark P Mattson,Jae Hyung Park, Dong-Gyu Jo
 
Articular chondrocyte network mediated by gap junctions: role in metabolic cartilage homeostasis
Maria D Mayan, Raquel Gago-Fuentes, Paula Carpintero-Fernandez, Patricia Fernandez-Puente, Purificacion Filgueira-Fernandez, Noa Goyanes, Virginijus Valiunas, Peter R Brink, Gary S Goldberg, Francisco J Blanco
 
Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo
Shouan Zhu, Ping Lu, Huanhuan Liu, Pengfei Chen, Yan Wu, Yanyan Wang, Heng Sun,Xiaolei Zhang, Qingqing Xia, Boon Chin Heng, Yiting Zhou, Hong Wei Ouyang
 
B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis
Laetitia Rapetti, Konstantia-Maria Chavele, Catherine M Evans, Michael R Ehrenstein
 
Free fatty acids: potential proinflammatory mediators in rheumatic diseases
Klaus W Frommer, Andreas Schäffler, Stefan Rehart, Angela Lehr, Ulf Müller-Ladner,Elena Neumann
 
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
K A van Schie, M H Hart, E R de Groot, S Kruithof, L A Aarden, G J Wolbink, T Rispens
 

Arthrotest


Arthritis & Rheumatism


Arthritis & Rheumatism
Volume 67, Issue 1 January 2015
Biomarkers of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Juan Chen, Tracy J. Doyle, Yongliang Liu, Rohit Aggarwal, Xiaoping Wang, Yonghong Shi, Sheng Xiang Ge, Heqing Huang, Qingyan Lin, Wen Liu, Yongjin Cai, Diane Koontz, Carl R. Fuhrman, Maria F. Golzarri, Yushi Liu, Hiroto Hatabu, Mizuki Nishino, Tetsuro Araki, Paul F. Dellaripa, Chester V. Oddis, Ivan O. Rosas and Dana P. Ascherman
 
Transcription Factor Snail Regulates Tumor Necrosis Factor α-Mediated Synovial Fibroblast Activation in the Rheumatoid Joint
Shih-Yao Chen, Ai-Li Shiau, Yuan-Tsung Li, Chi-Chen Lin, I-Ming Jou, Ming-Fei Liu, Chao-Liang Wu and Chrong-Reen Wang
 
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody
Jens A. A. Fischer, Axel J. Hueber, Stacy Wilson, Margarete Galm, Wolfgang Baum, Christopher Kitson, Johannes Auer, Stefan H. Lorenz, Jörg Moelleken, Martin Bader, Alain C. Tissot, Seng-Lai Tan, Stefan Seeber and Georg Schett
 
Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy
Shigeru Iwata, Shingo Nakayamada, Shunsuke Fukuyo, Satoshi Kubo, Naoki Yunoue, Sheau-Pey Wang, Maiko Yoshikawa, Kazuyoshi Saito and Yoshiya Tanaka
 
Expression and Function of Aminopeptidase N/CD13 Produced by Fibroblast-like Synoviocytes in Rheumatoid Arthritis: Role of CD13 in Chemotaxis of Cytokine-Activated T Cells Independent of Enzymatic Activity
Rachel Morgan, Judith Endres, Nilofar Behbahani-Nejad, Kristine Phillips, Jeffrey H. Ruth, Sean C. Friday, Gautam Edhayan, Thomas Lanigan, Andrew Urquhart, Kevin C. Chung and David A. Fox
 
Prolonged Tumor Necrosis Factor α Primes Fibroblast-like Synoviocytes in a Gene-Specific Manner by Altering Chromatin
Christopher Sohn, Angela Lee, Yu Qiao, Konstantinos Loupasakis, Lionel B. Ivashkiv and George D. Kalliolias
 
KCa1.1 Inhibition Attenuates Fibroblast-like Synoviocyte Invasiveness and Ameliorates Disease in Rat Models of Rheumatoid Arthritis
Mark R. Tanner, Xueyou Hu, Redwan Huq, Rajeev B. Tajhya, Liang Sun, Fatima S. Khan, Teresina Laragione, Frank T. Horrigan, Pércio S. Gulko and Christine Beeton
 
Antibiotic-Killed Staphylococcus aureus Induces Destructive Arthritis in Mice
Abukar Ali, Xuefeng Zhu, Jakub Kwiecinski, Inger Gjertsson, Catharina Lindholm, Yoichiro Iwakura, Xiaoyang Wang, Nils Lycke, Elisabet Josefsson, Rille Pullerits and Tao Jin
 
Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta-Analysis
Alejandro Souto, Eva Salgado, José Ramón Maneiro, Antonio Mera, Loreto Carmona and Juan J. Gómez-Reino
 
Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
Jose U. Scher, Carles Ubeda, Alejandro Artacho, Mukundan Attur, Sandrine Isaac, Soumya M. Reddy, Shoshana Marmon, Andrea Neimann, Samuel Brusca, Tejas Patel, Julia Manasson, Eric G. Pamer, Dan R. Littman and Steven B. Abramson
 
Genetic Dissection of Acute Anterior Uveitis Reveals Similarities and Differences in Associations Observed With Ankylosing Spondylitis
Philip C. Robinson, Theodora A. M. Claushuis, Adrian Cortes, Tammy M. Martin, David M. Evans, Paul Leo, Pamela Mukhopadhyay, Linda A. Bradbury, Katie Cremin, Jessica Harris, Walter P. Maksymowych, Robert D. Inman, Proton Rahman, Nigil Haroon, Lianne Gensler, Joseph E. Powell, Irene E. van der Horst-Bruinsma, Alex W. Hewitt, Jamie E. Craig, Lyndell L. Lim, Denis Wakefield, Peter McCluskey, Valentina Voigt, Peter Fleming, Spondyloarthritis Research Consortium of Canada, Australio-Anglo-American Spondylitis Consortium, International Genetics of Ankylosing Spondylitis Consortium, Wellcome Trust Case Control Study 2, Mariapia Degli-Esposti, Jennifer J. Pointon, Michael H. Weisman, B. Paul Wordsworth, John D. Reveille, James T. Rosenbaum and Matthew A. Brown
 
Five-Year Followup of Knee Joint Cartilage Thickness Changes After Acute Rupture of the Anterior Cruciate Ligament.
F. Eckstein, W. Wirth, L. S. Lohmander, M. I. Hudelmaier and R. B. Frobell
 
Intraarticular Hip Injection and Early Revision Surgery Following Total Hip Arthroplasty: A Retrospective Cohort Study.
Bheeshma Ravi, Benjamin G. Escott, David Wasserstein, Ruth Croxford, Simon Hollands, J. Michael Paterson, Hans J. Kreder and Gillian A. Hawker
 
The Mediating Effect of Leptin on the Relationship Between Body Weight and Knee Osteoarthritis in Older Adults
Angela Fowler-Brown, Dae Hyun Kim, Ling Shi, Edward Marcantonio, Christina C. Wee, Robert H. Shmerling and Suzanne Leveille
 
Genome-Wide Association Study Identifies ITPR2 as a Susceptibility Gene for Kashin-Beck Disease in Han Chinese
Feng Zhang, Yan Wen, Xiong Guo, Yingang Zhang, Xi Wang, Tielin Yang, Hui Shen, Xiangding Chen, Qing Tian and Hong-Wen Deng
 
Endothelial Cells Enhance the Migration of Bovine Meniscus Cells
Xiaoning Yuan, George M. Eng, Derya E. Arkonac, Pen-hsiu Grace Chao and Gordana Vunjak-Novakovic
 
Association of Anti-Acidic Ribosomal Protein P0 and Anti-Galectin 3 Antibodies With the Development of Skin Lesions in Systemic Lupus Erythematosus
Zhen-rui Shi, Guo-zhen Tan, Zhen Meng, Min Yu, Kai-wen Li, Jing Yin, Kai-hua Wei, Yi-jin Luo, Shu-qing Jia, Shu-juan Zhang, Jian Wu, Xiang-bin Mi and Liangchun Wang
 
Anti-Ribosomal P Protein Autoantibodies From Patients With Neuropsychiatric Lupus Impair Memory in Mice
Marcela Bravo-Zehnder, Enrique M. Toledo, Fabián Segovia-Miranda, Felipe G. Serrano, María J. Benito, Claudia Metz, Claudio Retamal, Alejandra Álvarez, Loreto Massardo, Nibaldo C. Inestrosa and Alfonso González
 
Dual B Cell Immunotherapy Is Superior to Individual Anti-CD20 Depletion or BAFF Blockade in Murine Models of Spontaneous or Accelerated Lupus
WeiYu Lin, Dhaya Seshasayee, Wyne P. Lee, Patrick Caplazi, Sami McVay, Eric Suto, Allen Nguyen, Zhonghua Lin, Yonglian Sun, Laura DeForge, Mercedesz Balazs, Flavius Martin and Ali A. Zarrin
 
Mechanisms of Tumor Necrosis Factor α Antagonist-Induced Lupus in a Murine Model
Yuan Xu, Haoyang Zhuang, Shuhong Han, Chao Liu, Hai Wang, Clayton E. Mathews, John Massini, Lijun Yang and Westley H. Reeves
 
Relationship of Age and Body Mass Index to Skin Temperature and Skin Perfusion in Primary Raynaud’s Phenomenon
Georgiana-Aura Giurgea, Wolfgang Mlekusch, Silvia Charwat-Resl, Markus Mueller, Alexandra Hammer, Michael E. Gschwandtner, Renate Koppensteiner and Oliver Schlager
 
Failed Degradation of JunB Contributes to Overproduction of Type I Collagen and Development of Dermal Fibrosis in Patients With Systemic Sclerosis
Markella Ponticos, Ioannis Papaioannou, Shiwen Xu, Alan M. Holmes, Korsa Khan, Christopher P. Denton, George Bou-Gharios and David J. Abraham
 
Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis
Takehiro Takahashi, Yoshihide Asano, Yohei Ichimura, Tetsuo Toyama, Takashi Taniguchi, Shinji Noda, Kaname Akamata, Yayoi Tada, Makoto Sugaya, Takafumi Kadono and Shinichi Sato
 
Expression of the Dermatomyositis Autoantigen Transcription Intermediary Factor 1γ in Regenerating Muscle
Payam Mohassel, Paul Rosen, Livia Casciola-Rosen, Katherine Pak and Andrew L. Mammen
 
Risk of Incident Diabetes in Patients With Gout: A Cohort Study
Seoyoung C. Kim, Jun Liu and Daniel H. Solomon
 
NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Variant Decreases the Risk of Renal Underexcretion Gout
Toshinori Chiba, Hirotaka Matsuo, Yusuke Kawamura, Shushi Nagamori, Takashi Nishiyama, Ling Wei, Akiyoshi Nakayama, Takahiro Nakamura, Masayuki Sakiyama, Tappei Takada, Yutaka Taketani, Shino Suma, Mariko Naito, Takashi Oda, Hiroo Kumagai, Yoshinori Moriyama, Kimiyoshi Ichida, Toru Shimizu, Yoshikatsu Kanai and Nariyoshi Shinomiya
 
Association of a Mutation in LACC1 With a Monogenic Form of Systemic Juvenile Idiopathic Arthritis
Salma M. Wakil, Dorota M. Monies, Mohamed Abouelhoda, Nada Al-Tassan, Haya Al-Dusery, Ewa A. Naim, Banan Al-Younes, Jameela Shinwari, Futwan A. Al-Mohanna, Brian F. Meyer and Sulaiman Al-Mayouf
 
No Excess Risks in Offspring With Paternal Preconception Exposure to Disease-Modifying Antirheumatic Drugs
Marianne Wallenius, Elisabeth Lie, Anne K. Daltveit, Kjell Å. Salvesen, Johan F. Skomsvoll, Synøve Kalstad, Åse S. Lexberg, Knut Mikkelsen, Tore K. Kvien and Monika Østensen
 
Enhanced Chondrogenesis of Induced Pluripotent Stem Cells From Patients With Neonatal-Onset Multisystem Inflammatory Disease Occurs via the Caspase 1-Independent cAMP/Protein Kinase A/CREB Pathway
Koji Yokoyama, Makoto Ikeya, Katsutsugu Umeda, Hirotsugu Oda, Seishiro Nodomi, Akira Nasu, Yoshihisa Matsumoto, Kazushi Izawa, Kazuhiko Horigome, Toshimasa Kusaka, Takayuki Tanaka, Megumu K. Saito, Takahiro Yasumi, Ryuta Nishikomori, Osamu Ohara, Naoki Nakayama, Tatsutoshi Nakahata, Toshio Heike and Junya Toguchida